| EINNR |
EIN Diagnosis |
WHO Diagnosis |
Outcome |
D-Score |
VPS |
| 4 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
-0.1 |
61.2 |
| 16 |
Proliferative |
atypical hyperplasia |
no cancer |
1 |
71.8 |
| 62 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
1.8 |
66.4 |
| 70 |
EIN |
atypical hyperplasia |
carcinoma |
-0.3 |
65 |
| 79 |
EIN |
atypical hyperplasia |
carcinoma |
-2.7 |
17.7 |
| 101 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
1.8 |
58.3 |
| 120 |
Polyp |
atypical hyperplasia |
no cancer |
3 |
54.8 |
| 129 |
Menstrual |
atypical hyperplasia |
no cancer |
2.5 |
66.7 |
| 132 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.7 |
62.4 |
| 155 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
3 |
38.6 |
| 171 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
1.9 |
65 |
| 173 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.8 |
65.7 |
| 208 |
EIN |
simple non-atypical hyperplasia |
carcinoma |
-1.6 |
34 |
| 223 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
3.5 |
76.3 |
| 268 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
3 |
74.1 |
| 290 |
Polyp |
atypical hyperplasia |
carcinoma |
0.3 |
61.6 |
| 291 |
EIN |
atypical hyperplasia |
no cancer |
1.2 |
60.3 |
| 298 |
Menstrual |
atypical hyperplasia |
no cancer |
1.4 |
55.2 |
| 342 |
EIN |
simple non-atypical hyperplasia |
no cancer |
1.4 |
65.5 |
| 368 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.1 |
64.4 |
| 427 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.9 |
72.5 |
| 436 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2 |
76.1 |
| 453 |
Menstrual |
atypical hyperplasia |
no cancer |
1.9 |
65.3 |
| 464 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
2.6 |
66.9 |
| 523 |
Anovulation |
atypical hyperplasia |
no cancer |
2.2 |
66.1 |
| 529 |
EIN |
atypical hyperplasia |
carcinoma |
-0.1 |
56 |
| 531 |
EIN |
atypical hyperplasia |
no cancer |
-1 |
41.1 |
| 578 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.9 |
69.7 |
| 581 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
2.2 |
78.8 |
| 603 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
2.8 |
81.4 |
| 605 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
1.5 |
60 |
| 616 |
EIN |
atypical hyperplasia |
carcinoma |
-1.3 |
34.5 |
| 620 |
Menstrual |
simple non-atypical hyperplasia |
no cancer |
3.7 |
73.5 |
| 632 |
EIN |
simple non-atypical hyperplasia |
no cancer |
-0.2 |
49.4 |
| 642 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
2.2 |
66.8 |
| 664 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.8 |
70.9 |
| 665 |
Polyp |
simple non-atypical hyperplasia |
no cancer |
2.1 |
66.2 |
| 679 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
1.7 |
66.7 |
| 753 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
4.1 |
77 |
| 755 |
EIN |
atypical hyperplasia |
carcinoma |
-1.2 |
40.4 |
| 756 |
Anovulation |
simple non-atypical hyperplasia |
no cancer |
2.1 |
66.7 |
| 762 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
2.2 |
79.5 |
| 765 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
2.6 |
82.5 |
| 847 |
Polyp |
atypical hyperplasia |
no cancer |
1.3 |
61.8 |
| 898 |
Menstrual |
simple non-atypical hyperplasia |
no cancer |
1.2 |
61.1 |
| 945 |
Anovulation |
atypical hyperplasia |
no cancer |
1.8 |
65.3 |
| 950 |
Polyp |
atypical hyperplasia |
no cancer |
0.2 |
57.1 |
| 983 |
EIN |
atypical hyperplasia |
carcinoma |
-2.2 |
28.3 |
| 993 |
Proliferative |
simple non-atypical hyperplasia |
no cancer |
1.8 |
62.4 |
| 996 |
EIN |
simple non-atypical hyperplasia |
no cancer |
0.4 |
44.2 |
|
|
|
|
|
|